Mechanism of tumor remission by cytomegalovirus in a murine lymphoma model: evidence for involvement of virally induced cellular interleukin-15
- PMID: 25805565
- DOI: 10.1007/s00430-015-0408-z
Mechanism of tumor remission by cytomegalovirus in a murine lymphoma model: evidence for involvement of virally induced cellular interleukin-15
Abstract
A murine model of B and T cell lymphomas in recipients after hematoablative conditioning for hematopoietic cell transplantation (HCT) has previously revealed a tumor-repressive, metastasis-inhibiting function of murine cytomegalovirus (mCMV). More recently, this prediction from the experimental model was put on trial in several clinical studies that indeed gave evidence for a lower incidence of tumor relapse associated with early reactivation of latent human cytomegalovirus (hCMV) after allogeneic HCT in patients treated against different types of hematopoietic malignancies, including lymphoma and acute as well as chronic leukemias. Due to the limitations inherent to clinical studies, the tumor-repressive role of hCMV remained observational with no approach to clarify mechanisms. Although the tumor-repressive mechanisms of mCMV and hCMV may differ and depend on the type of tumor, experimental approaches in the murine model might give valuable hints for concepts to follow in clinical research. We have previously shown for the liver-adapted A20-derived B cell lymphoma E12E that mCMV does not infect the lymphoma cells for causing cell death by viral cytopathogenicity but triggers tumor-selective apoptosis at a tissue site of tumor metastasis distant from a local site of infection. This finding suggested involvement of a cytokine that triggers apoptosis, directly or indirectly. Here we used a series of differential high-density microarray analyses to identify cellular genes whose expression is specifically upregulated at the site of virus entry only by viruses capable of triggering lymphoma cell apoptosis. This strategy identified interleukin-15 (IL-15) as most promising candidate, eventually confirmed by lymphoma repression with recombinant IL-15.
Similar articles
-
Lymphoma cell apoptosis in the liver induced by distant murine cytomegalovirus infection.J Virol. 2006 May;80(10):4801-19. doi: 10.1128/JVI.80.10.4801-4819.2006. J Virol. 2006. PMID: 16641273 Free PMC article.
-
Mast cells: innate attractors recruiting protective CD8 T cells to sites of cytomegalovirus infection.Med Microbiol Immunol. 2015 Jun;204(3):327-34. doi: 10.1007/s00430-015-0386-1. Epub 2015 Feb 4. Med Microbiol Immunol. 2015. PMID: 25648117 Review.
-
Tumor control in a model of bone marrow transplantation and acute liver-infiltrating B-cell lymphoma: an unpredicted novel function of cytomegalovirus.J Virol. 2002 Mar;76(6):2857-70. doi: 10.1128/jvi.76.6.2857-2870.2002. J Virol. 2002. PMID: 11861853 Free PMC article.
-
New interleukin-15 superagonist (IL-15SA) significantly enhances graft-versus-tumor activity.Oncotarget. 2017 Jul 4;8(27):44366-44378. doi: 10.18632/oncotarget.17875. Oncotarget. 2017. PMID: 28574833 Free PMC article.
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
Cited by
-
From Vaccine Vector to Oncomodulation: Understanding the Complex Interplay between CMV and Cancer.Vaccines (Basel). 2019 Jul 9;7(3):62. doi: 10.3390/vaccines7030062. Vaccines (Basel). 2019. PMID: 31323930 Free PMC article. Review.
-
STING Sensing of Murine Cytomegalovirus Alters the Tumor Microenvironment to Promote Antitumor Immunity.J Immunol. 2020 Jun 1;204(11):2961-2972. doi: 10.4049/jimmunol.1901136. Epub 2020 Apr 13. J Immunol. 2020. PMID: 32284333 Free PMC article.
-
Not just leukemia: CMV may protect against lymphoma recurrence after allogeneic transplant.Leuk Lymphoma. 2017 Apr;58(4):759-761. doi: 10.1080/10428194.2016.1239265. Epub 2016 Oct 12. Leuk Lymphoma. 2017. PMID: 27733072 Free PMC article. No abstract available.
-
Murine Cytomegalovirus Infection of Melanoma Lesions Delays Tumor Growth by Recruiting and Repolarizing Monocytic Phagocytes in the Tumor.J Virol. 2019 Sep 30;93(20):e00533-19. doi: 10.1128/JVI.00533-19. Print 2019 Oct 15. J Virol. 2019. PMID: 31375579 Free PMC article.
-
Direct Evidence for Viral Antigen Presentation during Latent Cytomegalovirus Infection.Pathogens. 2021 Jun 10;10(6):731. doi: 10.3390/pathogens10060731. Pathogens. 2021. PMID: 34200578 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical